2014, Number s1
<< Back Next >>
Gac Med Mex 2014; 150 (s1)
Prevalence of sexual function alterations in mexican subjects with type 1 and type 2 diabetes mellitus in a High-Specialty Medical Unit
Coronado CIA, Escalante PJM, Celis RAJ
Language: Spanish
References: 42
Page: 107-113
PDF size: 222.94 Kb.
ABSTRACT
Objective: To determine the prevalence of sexual function alterations in Mexican subjects with diabetes mellitus (DM)
attended in a highly specialized medical unit.
Material and methods: Sociodemographic variables were evaluated, and
the DM, male and female sexual function with an ad hoc questionnaire and Female Sexual Function Index or International
Index of Erectile Function. Data were processed using the SPSS statistical analysis program version 19.
Results: 212 subjects
were selected, 120 women and 92 men. The global prevalence of sexual function alterations was 81.1%. In women it
was 83.3% and 78.3% in men, with 73.7% and 63.1%, respectively, in those under 40 years of age. The highest prevalence
occurred among women aged 50-59 years and men between 60-69 (± 95%), married (› 80%), pensioners and
women of the household (› 90%), with primary educational level (100%), men with type 1 DM or women with type 2 DM
(› 85%), and with 21 years or more of DM diagnosis (90-100%).
Conclusion: The prevalence of sexual function alterations
in Mexican subjects with DM is higher than worldwide reported; women have higher prevalence of sexual function
alterations than men.
REFERENCES
OMS. 10 datos sobre la diabetes. Ginebra: Organización Mundial de la Salud; Datos y Cifras; septiembre de 2012. [Internet]. Consultado el 18 de enero de 2014 (aproximadamente 10 pantallas). Disponible en: http:// www.who.int/features/factfiles/diabetes/facts/es/index9.html.
FMD. Diabetes en México. México, D.F.: Federación Mexicana de Diabetes, A.C.; Diabetes en números; 2010 feb. 10. [Internet]. Consultado el 19 de enero de 2014 (aproximadamente 8 pantallas). Disponible en: http://www.fmdiabetes.org/fmd/pag/diabetes_ numeros. php.
Mezones-Holguin E, Blümel JE, Huezo M, et al. Impact of diabetes mellitus on the sexuality of Peruvian postmenopausal. Gynecol Endocrinol. 2008;24(8):470-4.
Doruk H, Akbay E, Cayan S, Akbay E, Bozlu M, Acar D. Effect of diabetes mellitus on female sexual function and risk factors. Arch Androl. 2005;51(1):1-6.
De Berardis G, Pellegrini F, Franciosi M, et al. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. Diabetes Care. 2005;28(11):2637-43.
Giraldi A, Kristensen E. Sexual dysfunction in women with diabetes mellitus. J Sex Res. 2010;47(2):199-211.
Romero J, Licea M. Disfunción sexual eréctil en la diabetes mellitus. Rev Cubana Endocrinol. 2000;11:105-20.
Agramonte A, Navarro D, Domínguez E, García C, Navarro O. Respuesta sexual de la mujer de edad mediana con diabetes mellitus. Rev Cubana Endocrinol. 2002;13(3). [Internet] Consultado el 13 de enero de 2014. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1561-29532002000300003&lng=es.
Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care. 2002;25(4):672-7.
Hass K. Abnormal Psychology. Nueva York, EE.UU.: Van Nostrand Company; 1979.
Masters W, Johnson V. Human sexual inadequacy. Boston, EE.UU.: Little Brown; 1970.
Wiener D. Sexual problems in clinical experience. En: Broderick C, Bernard J, eds. The individual sex and society. Baltimore, EE.UU.: John Hopkins University Press; 1969.
Sánchez C, Carreño J, Martínez S, Gómez M. Disfunciones sexuales femeninas y masculinas: comparación de género en una muestra de la ciudad de México. Salud Ment. 2005;28:74-80.
Sánchez C, Corres N, Carreño J, Henales C. Perfiles de los indicadores relacionados con las disfunciones sexuales masculinas: trastorno de la erección, trastorno del orgasmo y eyaculación precoz. Salud Ment. 2010;33:237-42.
Ugarte F, Barroso J. Prevalencia de disfunción eréctil en México y factores de riesgo asociados. Rev Mex Urol. 2001;61:63-76.
Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction 3 - Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369(9561):597-611.
Malavige L, Jayaratne S, Kathriarachchi S, Sivayogan, S, Fernando D, Levy J. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J Sex Med. 2008;5(9):2125-34.
May M, Gralla O, Knoll N, et al. Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the ‘Cottbus Survey’ with 10 000 men. BJU Int. 2007;100(5):1110-5.
Yaman O, Akand M, Gursoy A, Erdogan M, Anafarta K. The effect of diabetes mellitus treatment and good glycemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: A pilot study. J Sex Med. 2006;3(2):344-8.
Aversa A, Isidori A, Gianfrilli D, et al. Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service. J Endocrinol Invest. 2004;27:548-56.
Enzlin P, Rosen R, Wiegel M, et al. Sexual Dysfunction in Women With Type 1 Diabetes Long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32(5):780-5.
Jiann B, Lu C, Lam H, Chu C, Sun C, Lee J. Patterns and their correlates of seeking treatment for erectile dysfunction in type 2 diabetic patients. J Sex Med. 2009;6(7):2008-16.
Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol. 2010;50(8):1-8.
Díaz J, Rubio E. Manejo clínico de la problemática sexual. Pac Psiquiatría- 1 vol. A3. México: 1997 [Internet]. Consultado el 5 de marzo de 2011. Disponible en: http://www.amssac.org/biblioteca/disfunciones-sexuales/.
Böhm M, Baumhäkel M, Probstfield J, et al. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J. 2007;154(1):94-101.
Fong E, Azuara A. Prevalencia de disfunción eréctil en pacientes diabéticos. Med Int Mex. 2007;23:477-80.
Ley general de salud. Reglamento de la ley general de salud en materia de investigación para la salud. México, D.F.: Secretaría de Salud; c 1984. [Internet] Consultado el 11 de enero de 2011. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/compi/rlgsmis.html.
Celis A. Bioestadística. México, D.F.: El Manual Moderno; 2004.
American Diabetes Association. Standards of medical care in diabetes- 2010. Diabetes Care. 2010;33 Suppl 1:S11-61.
Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
Blümel J, Binfa L, Cataldo L, Carrasco A, Izaguirre H, Sarrá S. Índice de función sexual femenina: un test para evaluar la sexualidad de la mujer. Rev Chil Obstet Ginecol. 2004;69:118-25.
Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assesment of erectile dysfunction. Urology. 1997;49(6):822-30.
Quek K, Low W, Razack A, Chua C, Loh C, Diublin N. The performance properties of the International Index of Erectile Function (IIEF-15) in assessing erectile disfunction in patients with lower urinary tract symptoms. Med J Malaysia. 2002;57(4):445-53.
Penson D, Latini D, Lubeck D, Wallace K, Henning J, Lue T. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care. 2003;26(4):1093-9.
Dunn K, Croft P, Hackett G. Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health. 1999;53(3):144-8.
Erol B, Tefekli A, Ozbey I, et al. Sexual dysfunction in type II diabetic females: a comparative study. J Sex Marital Ther. 2002;28 Suppl 1:55-62.
Tulloch-Reid M, Walker S. Quality of life in Caribbean youth with diabetes. West Indian Med J. 2009;58(3):250-6.
Bonierbale M, Clement A, Loundou A, et al. A new evaluation concept and its measurement: “male sexual anticipating cognitions”. J Sex Med. 2006;3(1):96-103.
Barroso J, Ugarte F, Pimentel D. Prevalencia de disfunción eréctil en hombres de 18 a 40 años en México y factores de riesgo asociados. Perinatol Reprod Hum. 2001;15:254-61.
Diario Oficial de la Federación. Norma Oficial Mexicana NOM-015- SSA2-2010, Para la prevención, tratamiento y control de la diabetes mellitus. México, D.F.: Secretaría de Gobernación; 2010. Actualizado el 23 de noviembre de 2010. [Internet]. Consultado el 15 de enero de 2014. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=5168074&fecha= 23/11/2010.
Vlachopoulos C, Jackson G, Stefanadis C, Montorsi P. Erectile Dysfunction in the Cardiovascular Patient. Eur Heart J. 2013;34(27):2034-46.
Miner M, Esposito K, Guay A, Montorsi P, Goldstein I. Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med. 2012;9(3):641-51.